In the latest fiscal period Q1'27, NVDA reported total operating expenses consisting of 6.32B USD in R&D Expenses and 1.3B USD in SG&A Expenses. This represents the highest spending level in the recorded period, reflecting a continued commitment to resource allocation. From Q2'24 to Q1'27, the company's operating expenses have exhibited a consistent upward trend, with R&D Expenses serving as the primary driver of growth. R&D spending more than tripled from 2.04B USD to 6.32B USD during this timeframe, significantly outpacing the more gradual increase in SG&A Expenses. Notable acceleration in total expenditures occurred starting in Q4'26, highlighting a period of intensified investment in innovation and infrastructure.